Cerebral Cysticercosis Presenting With Recurrent Epileptic Seizures
- PMID: 32432012
- PMCID: PMC7233489
- DOI: 10.7759/cureus.8153
Cerebral Cysticercosis Presenting With Recurrent Epileptic Seizures
Abstract
Cerebral cysticercosis is the most common parasitic disease of the human nervous system. It is endemic to some tropical countries but has rarely been described in Vietnam. We report three cases of neurocysticercosis in patients from north-west Vietnam presenting with recurrent epileptic seizures. Hypereosinophilia and positive immunoglobulin G (IgG) antibodies to cysticercosis were detected in two patients and three patients, respectively. The brain MRI showed multiple ring-enhancing cerebral lesions with a well-defined border. Scolexes were demonstrated on fluid attenuation inversion recovery (FLAIR) sequence as small images associated with a hyperintense cyst wall. Treatment of cerebral cysticercosis infection with albendazole 15 mg/kg/day x 21 days along with antiepileptic drug therapy usually results in a favorable outcome. These results highlight that cerebral cysticercosis should be suspected in patients from an endemic area who present with headaches and/or epileptic seizures.
Keywords: cerebral cysticercosis; magnetic resonance imaging; seizure.
Copyright © 2020, Hong Van et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures




Similar articles
-
Natural history of solitary cerebral cysticercosis on serial magnetic resonance imaging and the effect of albendazole therapy on its evolution.J Neurol Sci. 2010 Jan 15;288(1-2):135-41. doi: 10.1016/j.jns.2009.09.018. Epub 2009 Oct 28. J Neurol Sci. 2010. PMID: 19875133 Clinical Trial.
-
Drug treatment of neurocysticercosis.Natl Med J India. 1997 Jul-Aug;10(4):173-7. Natl Med J India. 1997. PMID: 9325640 Review.
-
T2 relaxometry helps prognosticate seizure outcome in patients with solitary cerebral cysticercosis.J Neurol Sci. 2017 May 15;376:1-6. doi: 10.1016/j.jns.2017.02.052. Epub 2017 Feb 27. J Neurol Sci. 2017. PMID: 28431589 Clinical Trial.
-
Cysticercosis: an emerging parasitic disease.Am Fam Physician. 2007 Jul 1;76(1):91-6. Am Fam Physician. 2007. PMID: 17668846 Review.
-
Cerebral and subcutaneous cysticercosis treated with albendazole.Int J Dermatol. 1995 Aug;34(8):574-9. doi: 10.1111/j.1365-4362.1995.tb02959.x. Int J Dermatol. 1995. PMID: 7591443
Cited by
-
Cerebral cysticercosis mimicking subarachnoid hemorrhage: a case report.Chin Neurosurg J. 2021 Sep 2;7(1):39. doi: 10.1186/s41016-021-00258-w. Chin Neurosurg J. 2021. PMID: 34470663 Free PMC article.
References
-
- Overview of Taenia solium cysticercosis in West Africa. Weka RP, Kamani J, Cogan T, Eisler M, Morgan ER. Acta Trop. 2019;190:329–338. - PubMed
-
- Neurocysticercosis: updates on epidemiology, pathogenesis, diagnosis, and management. White AC Jr. Annu Rev Med. 2000;51:187–206. - PubMed
-
- Neglected tropical diseases: progress towards addressing the chronic pandemic. Molyneux DH, Savioli L, Engels D. Lancet. 2017;389:312–325. - PubMed
-
- Assessing the burden of human cysticercosis in Vietnam. Trung DD, Praet N, Cam TD, Lam BV, Manh HN, Gabriël S, Dorny P. Trop Med Int Health. 2013;18:352–356. - PubMed
Publication types
LinkOut - more resources
Full Text Sources